In a report published by Schiavoni et al. in 2011, low-dose CPX was shown to release significant amounts of type I IFN, leading to the superior induction of CD8α+ dendritic cells and priming of IFN-γ+ CD8+ T cells in an EG7 thymoma mouse model [33]. The gene discussed is CD8A; the disease is thymoma.